EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Constellation Brands, Inc.
EL7 Factor Analysis
How we score this
Overall69
Strong — clearly above market medianContrarianF 6/8Grey zoneBetter than 69% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
82
11.7x▲17.8xTop tier
▸
Growth
37
-10.0%▼7.1%Bottom tier
▸
Quality
80
11.0%▲4.5%Top tier
▸
Safety
53
3.6x▼2.6xAround median
▸
Capital Return
74
3.31%▲2.12%Top tier
▸
Momentum
26
-8.7%▼2.9%Bottom tier
▸
Sentiment
72
13▲3Top tier
STZ

STZ Constellation Brands, Inc.

Constellation Brands, Inc. · NYSE
Market Closed
122.45
▼ ⁦-1.10%⁩ (-1.36)
Market Cap$20.9B
Beta0.40
52w Low52w High
120.25168.60
Last Week
⁦-5.33%⁩
Last Month
⁦-8.61%⁩
Last 3 Months
⁦-13.93%⁩
Last Year
⁦-16.12%⁩
Fair Value
Current price$122
Analyst target · 7 analysts
$167
⁦+36%⁩
See it clearly undervalued
Range ⁦$132–$186⁩
vs
DCF (estimate)
$115
⁦-6%⁩
Sees it slightly overvalued
⁦7.9⁩% discount · ⁦0⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$115–$167⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 7 analysts setting price target
$163.80
⁦+33.8%⁩
Current Price $122.45·Median $167.00
Low
$132.00
High
$186.00
Current price
$122.45
Average target
$163.80
Street summary

Slight Decline in Consensus While Ratings Remain Stable

The consensus price target for STZ fell to 163.8 from 165.2, a decrease of 1.4 or 0.85% over one day, seven days, and 30 days, with no change in the number of analysts, which remains at 7. Nevertheless, the consensus remains above the current price of 122.45, while the range between 132 and 186 and the median of 167 reflect notable variation in estimates.

As of 2026-09-11
Revisions momentum · 30d
⁦-0.8%⁩
Average rating
★ 3.54
Buy
Analyst coverage
24
Buy conviction
58%
Mixed
Rating activity · 30d
0↑ · 0↓
Target dispersion
44%
Wide
Analyst ratings over time24 analysts rating
3
11
8
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.52 → 3.54
Recent analyst moves
  • = Reiterate2026-09-11
    Deutsche Bank
    Hold
  • = Reiterate2026-07-02
    Roth MKM
    Buy
  • = Reiterate2026-07-02
    Deutsche Bank
    Hold
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    11.67x
    4.61x36.85x
    Cheap
  • Forward P/E
    10.09x
    3.86x30.86x
    Cheap
  • EV / EBITDA
    10.18x
    2.86x22.90x
    Cheap
  • FCF Yield
    8.7%
    -37.4%14.9%
    Strong
  • Revenue Growth YoY
    -10.0%
    -16.7%29.2%
    Below average
  • EPS Growth YoY
    546.4%
    -135.4%136.3%
    Exceptional
  • Gross Margin
    52.6%
    9.2%67.5%
    Strong
  • ROIC
    11.0%
    -29.3%20.8%
    Strong
  • Net Debt / EBITDA
    3.63x
    0.61x4.86x
    Near median
  • Dividend Yield
    3.3%
    0.9%8.3%
    Moderate
  • Payout Ratio
    39.0%
    15.9%176.6%
    Low
  • Altman Z-Score
    2.64
    -4.825.90
    Above average
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-01 data

Company Overview

Constellation Brands manages a portfolio of beer and wine brands, including Modelo, Corona, Pacifico, Kim Crawford, and Mi CAMPO. The value-creation mechanism presented by management on the July 1, 2026 call focuses on expanding distribution and awareness for brands that are still scaling, then supporting the presence and consumer relevance of mature brands through marketing, revenue management, pricing architecture, and package sizes.

In Q1 fiscal 2027, Constellation Brands recorded revenue of $2.4 billion, gross profit of $1.3 billion, and net income of $653.8 million. These figures equate to an approximate gross margin of 54% and an approximate net income margin of 27%, compared with revenue of $1.9 billion, gross profit of $951.7 million, and net income of $154.6 million in Q4 fiscal 2026.

Within the beer portfolio, gross margin was 39% in Q1 fiscal 2027, with shipment growth of 1.8%, a 30-basis-point benefit from fixed-cost absorption, and a 20-basis-point benefit from pricing after the mix impact. In contrast, operating margin declined by 10 basis points, as the improvement in gross margin was offset by higher selling, general and administrative expenses and World Cup-related marketing spending.

What's Driving the Stock

  • Beer shipment volume grew by 1.8% in Q1 fiscal 2027, adding about 30 basis points to margin through greater fixed-cost absorption, alongside the continued cost-reduction program.
  • Management said on July 1, 2026 that Corona Non-Alcohol delivered strong double-digit growth and became the fourth-ranked brand in its category, even though the company has not yet allocated significant marketing investment to it, creating room to increase targeted support.
  • June 2026 readings showed modest, broad-based acceleration after weakness in April and May, although growth remained below the March 2026 level. Management noted that California was performing well, while Texas and Florida remained under pressure.
  • The company plans to increase marketing investment during Q2 and Q3 fiscal 2027, with marketing exceeding 10% of net sales in each quarter, focusing on the World Cup, college football, and NFL.
  • Management sees remaining gaps in Modelo Especial's distribution and unaided awareness, despite it being the number-one brand by value in the market, while the Corona Extra plan focuses on increasing everyday presence and execution at retail locations, restaurants, and bars.
  • Management said the Chelada business would become the third-largest ready-to-drink business if classified that way, giving Constellation Brands an established base for participating in demand for this category.

Buying & Selling Case

▲ Buying Case4 pts

  • +Q1 fiscal 2027 results support the company's ability to generate strong earnings, with net income of $653.8 million on revenue of $2.4 billion and an approximate gross margin of 54%.
  • +Potential growth combines brands that are still scaling with large, established brands; Modelo Especial still faces gaps in distribution and awareness, while Corona Non-Alcohol is growing at a double-digit rate and ranked fourth in its category by July 1, 2026.
  • +The beer gross margin of 39% in Q1 fiscal 2027 showed tangible benefits from higher shipments, cost reductions, and pricing, despite limited shipment growth of 1.8%.
  • +The portfolio of Pacifico, Corona Non-Alcohol, and Chelada provides sources of growth and diversification across different categories and consumption occasions, instead of relying entirely on a renewed acceleration in Modelo Especial and Corona Extra.

▼ Selling Case5 pts

  • −The fiscal 2027 outlook depends on a consumer facing a volatile economic environment and greater weakness in areas with high Hispanic population density; fuel prices rose by more than 50% on average from the end of fiscal 2026 to the Q1 fiscal 2027 peak, and management kept its beer sales outlook unchanged because of limited visibility.

Valuation

The analyst consensus is Buy, with an average price target of $165.2 and a wide range between $132 and $186. The average target is below the 52-week high of $168.6, while the highest target exceeds that level; this divergence reflects differing expectations regarding the recovery of Modelo Especial and Corona Extra and the company's ability to protect margins while increasing marketing spending.

BuyAnalyst target: $165.2(+34.9%)

Figures in the text are as of 2026-08-28; the live price is shown at the top of the page.

FAQ

How did STZ perform in Q1 fiscal 2027?

Revenue was $2.4 billion, gross profit was $1.3 billion, and net income was $653.8 million. This equates to an approximate gross margin of 54% and an approximate net income margin of 27%. In the beer business, gross margin was 39%, with shipment growth of 1.8%.

Why did Constellation Brands not raise its beer outlook after the start of fiscal 2027?

Management kept its beer net sales outlook unchanged on the July 1, 2026 call despite the strong start to shipments. It attributed the decision to volatile demand and limited economic visibility, after fuel prices rose by more than 50% on average from the end of fiscal 2026 to the Q1 fiscal 2027 peak. The company expects shipments and depletions to converge for fiscal 2027 as a whole after early seasonal shipments in the first quarter.

What is the problem with Modelo Especial and Corona Extra?

Questions on the July 1, 2026 call described Modelo Especial's performance as slow and Corona Extra as facing challenges, and management agreed that both brands faced headwinds. Management believes Modelo Especial still has gaps in distribution and unaided awareness, despite being the number-one brand by value in the market. Corona Extra needs greater presence, relevance, and everyday activation, while remaining the number-one brand in New York City and Miami, according to management.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • −Modelo Especial remained slow, and Corona Extra faced prolonged challenges through the July 1, 2026 call. Improving performance therefore requires the company to successfully close Modelo's distribution gaps and revitalize Corona's everyday presence, rather than merely sustaining growth in smaller brands.
  • −Management projected additional pressure on operating margins in Q2 and Q3 fiscal 2027, with marketing exceeding 10% of net sales and higher selling, general and administrative expenses related to preparing the Veracruz facility.
  • −A shift by some consumers toward ready-to-drink beverages with higher alcohol content could pressure consumption volumes or the portfolio mix; management discussed on July 1, 2026 the need to evaluate the impact of these products across the entire portfolio and carefully select areas for participation.
  • −The wide range of analyst targets, from $132 to $186, reveals significant divergence in estimates of the recovery path. The average target of $165.2 is also close to the upper end of the 52-week range of $168.6, making achievement of the optimistic scenario sensitive to a recovery in the core brands and margin stability.
  • What growth opportunities does STZ have outside its core alcoholic beer business?

    Corona Non-Alcohol delivered strong double-digit growth and became fourth in its category by the July 1, 2026 call. Management said it had not yet allocated significant investment to the product, providing an opportunity to test increased marketing and distribution support. In ready-to-drink beverages, management said Chelada would rank as the third-largest business in the category if measured that way, alongside a small brand with higher alcohol content.

    What is expected for STZ's margins during the rest of fiscal 2027?

    Management expected gross margins to remain strong in Q2 and Q3 fiscal 2027 but warned of additional pressure on operating margins. Marketing is scheduled to exceed 10% of net sales in each quarter, with spending supporting the World Cup, college football, and NFL. Selling, general and administrative expenses will also rise because of employees added to support the startup of the Veracruz facility during fiscal 2027.

    What does the analyst consensus say about STZ's valuation?

    The analyst consensus is Buy, with an average price target of $165.2. The target range extends from $132 to $186, compared with a 52-week range of $126.45 to $168.6. The average target is close to the top of the 52-week range, while the highest target assumes a move above that level, highlighting the valuation's sensitivity to a recovery in the core brands and margin stability.